Changgeng Qian

CIK 1402196 · View on SEC EDGAR ↗

Insider

First SEC filing: June 8, 2007 · Latest: June 8, 2007

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 15 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Jan. 7, 2011 CRIS A 31,508 31,508 Direct Acquired (price as of 2026-08-21)
Jan. 7, 2011 CRIS A 93,492 93,492 Direct Acquired (price as of 2026-08-21)
Feb. 2, 2010 CRIS A 39,063 39,063 Direct Acquired (price as of 2026-08-21)
Feb. 2, 2010 CRIS A 85,937 85,937 Direct Acquired (price as of 2026-08-21)
Feb. 5, 2009 CRIS A 159,790 159,790 Direct Acquired (price as of 2026-08-21)
Feb. 5, 2009 CRIS A 20,210 20,210 Direct Acquired (price as of 2026-08-21)
Feb. 5, 2009 CRIS A 159,790 159,790 Direct Acquired (price as of 2026-08-21)
Feb. 5, 2009 CRIS A 20,210 20,210 Direct Acquired (price as of 2026-08-21)
Oct. 24, 2008 CRIS A 51,000 $0.79 $40,290 51,000 Direct Acquired -99.9% (price as of 2026-08-21)
Jan. 25, 2008 CRIS A 124,925 124,925 Direct Acquired (price as of 2026-08-21)
Jan. 25, 2008 CRIS A 55,075 55,075 Direct Acquired (price as of 2026-08-21)
June 6, 2007 CRIS A 78,058 78,058 Direct Acquired (price as of 2026-08-21)
June 6, 2007 CRIS A 71,942 71,942 Direct Acquired (price as of 2026-08-21)
June 6, 2007 CRIS A 70,233 70,233 Direct Acquired (price as of 2026-08-21)
June 6, 2007 CRIS A 79,767 79,767 Direct Acquired (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Jan. 7, 2011 CRIS Non-qualified stock option (right to buy) Common stock (31,508) $2.15 Jan. 7, 2021 31,508 Acquired
Jan. 7, 2011 CRIS Qualified stock option (right to buy) Common stock (93,492) $2.15 Jan. 7, 2021 93,492 Acquired
Feb. 2, 2010 CRIS Qualified stock option (right to buy) Common stock (39,063) $2.27 Feb. 2, 2020 39,063 Acquired
Feb. 2, 2010 CRIS Non-qualified stock option (right to buy) Common stock (85,937) $2.27 Feb. 2, 2020 85,937 Acquired
Feb. 5, 2009 CRIS Non-qualified stock option (right to buy) Common stock (159,790) $1.07 Feb. 5, 2019 159,790 Acquired
Feb. 5, 2009 CRIS Qualified stock option (right to buy) Common stock (20,210) $1.07 Feb. 5, 2019 20,210 Acquired
Feb. 5, 2009 CRIS Non-qualified stock option (right to buy) Common stock (159,790) $1.07 Feb. 5, 2019 159,790 Acquired
Feb. 5, 2009 CRIS Qualified stock option (right to buy) Common stock (20,210) $1.07 Feb. 5, 2019 20,210 Acquired
Oct. 24, 2008 CRIS Non-qualified stock option (right to buy) Common stock (51,000) $0.79 Oct. 24, 2018 51,000 Acquired
Jan. 25, 2008 CRIS Non-qualified stock option (right to buy) Common stock (124,925) $1.43 Jan. 25, 2018 124,925 Acquired
Jan. 25, 2008 CRIS Qualified stock option (right to buy) Common stock (55,075) $1.43 Jan. 25, 2018 55,075 Acquired
June 6, 2007 CRIS Non-qualified stock option (right to buy) Common stock (78,058) $1.39 June 6, 2017 78,058 Acquired
June 6, 2007 CRIS Qualified stock option (right to buy) Common stock (71,942) $1.39 June 6, 2017 71,942 Acquired
June 6, 2007 CRIS Non-qualified stock option (right to buy) Common stock (70,233) $1.39 June 6, 2017 70,233 Acquired
June 6, 2007 CRIS Qualified stock option (right to buy) Common stock (79,767) $1.39 June 6, 2017 79,767 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 14 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
June 8, 2007 CRIS Common Stock [F8] 5,014 Direct
June 8, 2007 CRIS Qualified stock option (right to buy)→ Common stock (20,000) 20,000 Direct
June 8, 2007 CRIS Qualified stock option (right to buy)→ Common stock (10,125) 10,125 Direct
June 8, 2007 CRIS Qualified stock option (right to buy)→ Common stock (9,375) 9,375 Direct
June 8, 2007 CRIS Qualified stock option (right to buy)→ Common stock (35,000) 35,000 Direct
June 8, 2007 CRIS Qualified stock option (right to buy)→ Common stock (24,000) 24,000 Direct
June 8, 2007 CRIS Qualified stock option (right to buy)→ Common stock (24,000) 24,000 Direct
June 8, 2007 CRIS Qualified stock option (right to buy)→ Common stock (15,136) 15,136 Direct
June 8, 2007 CRIS Qualified stock option (right to buy)→ Common stock (20,000) 20,000 Direct
June 8, 2007 CRIS Qualified stock option (right to buy)→ Common stock (53,253) 53,253 Direct
June 8, 2007 CRIS Non-qualified stock option (right to buy)→ Common stock (864) 864 Direct
June 8, 2007 CRIS Non-qualified stock option (right to buy)→ Common stock (20,000) 20,000 Direct
June 8, 2007 CRIS Non-qualified stock option (right to buy)→ Common stock (46,747) 46,747 Direct
June 8, 2007 CRIS Qualified stock option (right to buy)→ Common stock (10,000) 10,000 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

CRIS

President, Research and Preclinical Development
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2011
2010
2009

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.